Which stocks have an unusual volume on Wednesday?
By Mill Chart
Last update: Jan 18, 2023
Let's have a look at what is happening on the US markets on Wednesday. Below you can find the stocks with an unusual volume in today's session.
Top unusual volume stocks
| Ticker | Change | Comment |
|---|---|---|
| CYAD | 13.68% | CELYAD ONCOLOGY-SPON ADR's (NASDAQ:CYAD) traded a high volume of 4.6M shares. The share price increased by 13.68%. This volume is 249.0% above the average 50 day volume. |
| CLXT | -19.3% | 4.48M shares of CALYXT INC (NASDAQ:CLXT) have been traded so far today. Leading to a price decrease of 19.3%. This volume is 119.0% above the average 50 day volume. Yesterday the company had a press release: CLXT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Calyxt, Inc. Is Fair to Shareholders. |
| BGSX | 0.0% | BUILD ACQUISITION CORP-A's (NYSE:BGSX) traded a high volume of 606.4K shares. This is 463.0% above the average daily volume of the last 50 days. |
| GNS | -9.45% | So far 4.04M shares of GENIUS GROUP LTD (NYSEARCA:GNS) have traded in today's session. Shares are falling by 9.45%. The average daily volume over 50 days is 616.24K, so this is 556.0% above the average volume. A press release (Genius Group Wins Real Leaders Impact Awards) was released earlier today. |
| NEON | 17.32% | 904.59K shares of NEONODE INC (NASDAQ:NEON) have been traded so far today. NASDAQ:NEON is advancing 17.32% today. This is 169.0% above the average daily volume of the last 50 days. |
| ATXI | -10.06% | AVENUE THERAPEUTICS INC (NASDAQ:ATXI) has an unusual volume of 11.68M shares. Leading to a price decrease of 10.06%. The average volume measured over 50 days is 804.85K, so this is 1.0K% above the average volume. |
| BIOL | -3.39% | 1.4M shares of BIOLASE INC (NASDAQ:BIOL) have been traded so far today. Leading to a price decrease of 3.39%. This is 207.0% above the average daily volume of the last 50 days. |
| FRXB | 0.0% | 912.48K shares of FOREST ROAD ACQUISITION CO-A (NYSE:FRXB) exchanged hands today. This volume is 248.0% above the average 50 day volume. |
| TCBP | 42.6% | 22.57M shares of TC BIOPHARM HOLDINGS PLC-ADR (NASDAQ:TCBP) have been traded so far today. Shares are rising by 42.6%. This volume is 4.0K% above the average 50 day volume. |
| BTCM | -8.26% | BIT MINING LTD - SPON ADR (NYSE:BTCM) has an unusual volume of 1.71M shares today. The share price decreased by 8.26%. The average daily volume over 50 days is 1.17M, so this is 46.44% above the average volume. |
Our unusual volume stocks screener will show you the full list.
AVENUE THERAPEUTICS INC
NASDAQ:ATXI (4/25/2024, 4:46:37 PM)
After market: 0.1016 -0.02 (-13.16%)0.117
+0.02 (+24.07%)
ATXI News
an hour ago - ChartmillGet insights into the top gainers and losers of Thursday's after-hours session.Which stocks are moving after the closing bell on Thursday?
a day ago - ChartmillTop movers in Wednesday's sessionLet's have a look at what is happening on the US markets one hour before the close of the markets on Wednesday. Below you can find the top gainers and losers in today's session.
a day ago - ChartmillTraders are paying attention to the gapping stocks in Wednesday's session. Let's dive into which stocks are experiencing notable gaps.Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Wednesday. Let's explore the market movements and identify the stocks with significant gaps.
MIAMI, April 24, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company...
16 days ago - ChartmillTop movers in Tuesday's after hours sessionGet insights into the top gainers and losers of Tuesday's after-hours session.
MIAMI, March 25, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company...
a month ago - BusinessInsiderATXI Stock Earnings: Avenue Therapeutics Beats EPS for Q4 2023InvestorPlace - Stock Market News, Stock Advice & Trading Tips Avenue Therapeutics (NASDAQ:ATXI) just reported results for the fourth quarter ...
a month ago - InvestorPlaceATXI Stock Earnings: Avenue Therapeutics Beats EPS for Q4 2023ATXI stock results show that Avenue Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023.
- Enrollment completed in Phase 1b/2a clinical trial of AJ201 for spinal and bulbar muscular atrophy; topline data expected in second quarter of 2024 - ...
MIAMI, March 15, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company...
BAER-101 demonstrated full suppression of seizure activity in SynapCell's GAERS model of absence epilepsy, a proven indicator of efficacy in anti-seizure...
-In vivo data supports BAER-101’s unique ability to significantly suppress seizures using the SynapCell's Genetic Absence Epilepsy Rat from Strasbourg...
